Study Suggests Affordable Vaccines Within Reach

Nov 03, 2009

(PhysOrg.com) -- A new research paper suggests that pharmaceutical companies can afford to produce less expensive vaccines for lower-income countries because the companies can recover their research and development (R&D) costs through the sale of the vaccine to higher-priced markets. The findings are included in an article co-authored by University of Victoria health economist Rebecca Warburton being published this week in the journal Vaccine.

The study focuses on the development of two new vaccines, RotaTeq (Merck) and Rotarix (GlaxoSmithKline or GSK), designed to combat the rotavirus which causes gastrointestinal illness and is estimated to kill 440,000 children under five years of age worldwide each year.

“Our study attempted to replace high, unverified research and development estimates with lower, more verifiable estimates for the vaccines based on detailed searches of public information and follow-up interviews with senior informants,” says Warburton who did the detailed calculations that appear in the paper. She worked on it with Dr. Donald Light, the Lorry Lokey Visiting Professor at Stanford University, who did the interviews and gathered the raw cost estimates. The other author was Jon Andrus of the Pan-American Health Organization. “Our estimates suggest that companies can recover their up-front costs quickly from affluent markets and thus can offer these vaccines to lower-income countries at a price they can afford,” she adds. “In this particular case, the costs were recovered within one year of the ’s release.”

The study team acknowledges that it can be difficult for to recover large R&D costs and make a reasonable profit selling vaccines at prices that lower-income countries can pay. As a result, many multinational firms have abandoned the vaccine field.

“Merck and GSK have remained committed and it’s important that they recover their R&D costs and earn a reasonable profit to fund future vaccine development,” says Warburton. “However, common R&D cost estimates from industry-supported studies are based on drugs rather than vaccines so we don’t really have accurate information about vaccine R&D costs.”

The research team feels their finding likely applies to other vaccines and calls for companies to make public their vaccine R&D costs. “Better vaccines are a shared project between companies and public health agencies,” says Warburton. “Greater transparency and consistency in reporting R&D is needed so that fair prices can be established.”

Provided by University of Victoria

Explore further: Police seize millions in huge fake Viagra swoop

add to favorites email to friend print save as pdf

Related Stories

WHO approves cervical cancer vaccine Cervarix

Jul 09, 2009

(AP) -- The World Health Organization has approved a second cervical cancer vaccine, this one made by GlaxoSmithKline, meaning U.N. agencies and partners can now officially buy millions of doses of the vaccine for poor countries ...

Do vaccines cause autism, asthma and diabetes?

Jun 11, 2008

Almost 70% of parents who refuse to vaccinate their children do so because they believe vaccines may cause harm. Indeed vaccines have been blamed for causing asthma, autism, diabetes, and many other conditions--most of which ...

Recommended for you

Novartis Japan admits concealing drug side effects

22 hours ago

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

Expression of privilege in vaccine refusal

Aug 27, 2014

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

User comments : 0